Join Drs. Herrera, Lynch, and Evens to stay abreast of the latest clinical evidence supporting the use of ICI-based regimens for adults with advanced cHL, and strategies for the management of immune-related AEs associated with the use of ICIs.
- Provider:Haymarket Medical Education
- Activity Link: https://www.mycme.com/courses/immune-checkpoint-inhibitors-for-advanced-hodgkin-lymphoma-in-adults-9794
- Start Date: 2024-10-31 05:00:00
- End Date: 2024-10-31 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 157615.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest